Tarsus Pharmaceuticals Inc
TARSHealthcare|Biotechnology|USA
$58.13
-6.00 (-9.35%)
Tangible Book
$7.95
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (150)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Azamian Bobak R. | President/CEO and Board Chair | 2026-06-17 | SELL | 10,000 | $61.55 | $615.5K |
| Farrow Jeffrey S | See Remarks | 2026-06-16 | SELL | 14,396 | $60.95 | $877.4K |
| Goodrich Katherine | Director | 2026-06-15 | SELL | 2,954 | $62.08 | $183.4K |
| LINK WILLIAM J PHD | Director | 2026-06-15 | SELL | 12,500 | $62.12 | $776.5K |
| Neervannan Seshadri | COO | 2026-03-20 | SELL | 2,989 | $66.75 | $199.5K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2026-03-19 | SELL | 12,274 | $68.36 | $839.1K |
| Wahl Bryan | General Counsel | 2026-03-19 | SELL | 12,440 | $68.36 | $850.4K |
| Neervannan Seshadri | COO | 2026-03-19 | SELL | 11,324 | $68.21 | $772.4K |
| Mottiwala Aziz | Chief Commercial Officer | 2026-03-19 | SELL | 13,056 | $68.36 | $892.5K |
| Lin Elizabeth Yeu | Chief Medical Officer | 2026-03-19 | SELL | 1,144 | $68.36 | $78.2K |
| Farrow Jeffrey S | See Remarks | 2026-03-19 | SELL | 6,430 | $68.36 | $439.6K |
| Azamian Bobak R. | President/CEO and Board Chair | 2026-03-19 | SELL | 34,603 | $68.34 | $2364.8K |
| LINK WILLIAM J PHD | Director | 2026-03-16 | SELL | 12,500 | $68.79 | $859.9K |
| Neervannan Seshadri | COO | 2026-03-04 | SELL | 8,366 | $76.67 | $641.4K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2026-01-02 | SELL | 15,565 | $80.67 | $1255.6K |
| Azamian Bobak R. | President/CEO and Board Chair | 2025-12-24 | SELL | 6,000 | $82.51 | $495.1K |
| Lin Elizabeth Yeu | Chief Medical Officer | 2025-12-16 | SELL | 2,078 | $79.5 | $165.2K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2025-12-16 | SELL | 7,397 | $80.1 | $592.5K |
| LINK WILLIAM J PHD | Director | 2025-12-15 | SELL | 22,946 | $81.26 | $1864.6K |
| Azamian Bobak R. | President/CEO and Board Chair | 2025-09-24 | SELL | 6,000 | $55.37 | $332.2K |
| LINK WILLIAM J PHD | Director | 2025-09-08 | SELL | 27,116 | $57 | $1545.6K |
| Azamian Bobak R. | President/CEO and Board Chair | 2025-08-11 | SELL | 6,000 | $50 | $300K |
| Farrow Jeffrey S | See Remarks | 2025-06-17 | SELL | 13,608 | $40.42 | $550K |
| Lin Elizabeth Yeu | Chief Medical Officer | 2025-06-16 | SELL | 1,006 | $41.08 | $41.3K |
| Mottiwala Aziz | Chief Commercial Officer | 2025-06-09 | SELL | 17,500 | $43.76 | $765.8K |
| Azamian Bobak R. | President/CEO and Board Chair | 2025-03-24 | SELL | 6,000 | $50 | $300K |
| Mottiwala Aziz | Chief Commercial Officer | 2025-03-20 | SELL | 10,565 | $47.88 | $505.9K |
| Neervannan Seshadri | COO | 2025-03-20 | SELL | 7,583 | $47.89 | $363.1K |
| Wahl Bryan | General Counsel | 2025-03-20 | SELL | 9,686 | $47.88 | $463.8K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2025-03-20 | SELL | 6,711 | $47.88 | $321.3K |
| Azamian Bobak R. | President/CEO and Board Chair | 2025-03-20 | SELL | 24,216 | $48.03 | $1163.1K |
| Farrow Jeffrey S | See Remarks | 2025-03-20 | SELL | 3,724 | $47.88 | $178.3K |
| LINK WILLIAM J PHD | Director | 2024-08-12 | SELL | 35,000 | $26.08 | $912.8K |
| Farrow Jeffrey S | See Remarks | 2024-06-18 | SELL | 10,445 | $27.47 | $286.9K |
| Mottiwala Aziz | Chief Commercial Officer | 2024-03-18 | SELL | 4,766 | $30.6 | $145.8K |
| Wahl Bryan | General Counsel | 2024-03-18 | SELL | 4,436 | $30.6 | $135.7K |
| Azamian Bobak R. | President/CEO and Board Chair | 2024-03-18 | SELL | 10,415 | $30.6 | $318.7K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2024-03-18 | SELL | 4,314 | $30.6 | $132K |
| Neervannan Seshadri | COO | 2024-03-18 | SELL | 4,879 | $30.6 | $149.3K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-12-27 | SELL | 8,000 | $20.22 | $161.8K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-12-20 | SELL | 40,000 | $20.27 | $810.8K |
| Trevejo Jose M. | CHIEF MEDICAL OFFICER | 2023-12-20 | SELL | 2,252 | $20 | $45K |
| Goldberg Andrew D. | Director | 2023-12-15 | BUY | 1,000 | $18.96 | $19K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2023-11-30 | SELL | 8,355 | $16.31 | $136.3K |
| Wahl Bryan | General Counsel | 2023-11-30 | SELL | 8,356 | $16.31 | $136.3K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-11-15 | SELL | 8,000 | $18.37 | $147K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-10-18 | SELL | 8,000 | $13.24 | $105.9K |
| Trevejo Jose M. | CHIEF MEDICAL OFFICER | 2023-10-05 | SELL | 1,604 | $18 | $28.9K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-09-20 | SELL | 8,000 | $17.21 | $137.7K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-08-23 | SELL | 8,000 | $17.23 | $137.8K |
| Lin Elizabeth Yeu | Director | 2023-08-15 | BUY | 9,506 | $16.8 | $159.7K |
| Mottiwala Aziz | Chief Commercial Officer | 2023-07-19 | SELL | 2,400 | $20.05 | $48.1K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-07-19 | SELL | 103,900 | $20.01 | $2079K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-07-12 | SELL | 9,000 | $17.35 | $156.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-06-21 | SELL | 8,000 | $18.63 | $149K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-06-14 | SELL | 9,000 | $18.58 | $167.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-06-08 | SELL | 3,100 | $20.01 | $62K |
| Mottiwala Aziz | Chief Commercial Officer | 2023-06-08 | SELL | 100 | $20 | $2K |
| Mottiwala Aziz | Chief Commercial Officer | 2023-06-07 | SELL | 4,643 | $19 | $88.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-05-17 | SELL | 8,000 | $15.9 | $127.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-05-10 | SELL | 9,000 | $16.8 | $151.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-05-01 | SELL | 10,119 | $15.11 | $152.9K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-04-21 | SELL | 2,311 | $15.03 | $34.7K |
| Greenstein Leonard M. | CFO | 2023-04-20 | SELL | 5,000 | $14.02 | $70.1K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-04-19 | SELL | 8,000 | $13.6 | $108.8K |
| Greenstein Leonard M. | CFO | 2023-03-23 | SELL | 1,004 | $12.55 | $12.6K |
| Trevejo Jose M. | CHIEF MEDICAL OFFICER | 2023-03-23 | SELL | 1,513 | $12.58 | $19K |
| Neervannan Seshadri | COO | 2023-03-23 | SELL | 1,141 | $12.55 | $14.3K |
| Wahl Bryan | General Counsel | 2023-03-23 | SELL | 1,078 | $12.55 | $13.5K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-03-23 | SELL | 2,125 | $12.55 | $26.7K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2023-03-23 | SELL | 1,004 | $12.55 | $12.6K |
| Mottiwala Aziz | Chief Commercial Officer | 2023-03-23 | SELL | 1,078 | $12.55 | $13.5K |
| Holdbrook Mark J. | V.P., Clinical Affairs | 2023-03-20 | SELL | 386 | $12.94 | $5K |
| Greenstein Leonard M. | CFO | 2023-03-20 | SELL | 649 | $12.94 | $8.4K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-03-20 | SELL | 1,536 | $12.96 | $19.9K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2023-03-20 | SELL | 649 | $12.94 | $8.4K |
| Wahl Bryan | General Counsel | 2023-03-20 | SELL | 696 | $12.94 | $9K |
| Neervannan Seshadri | COO | 2023-03-20 | SELL | 740 | $12.94 | $9.6K |
| Trevejo Jose M. | CHIEF MEDICAL OFFICER | 2023-03-20 | SELL | 1,034 | $12.94 | $13.4K |
| Mottiwala Aziz | Chief Commercial Officer | 2023-03-20 | SELL | 697 | $12.94 | $9K |
| Holdbrook Mark J. | V.P., Clinical Affairs | 2023-03-16 | SELL | 187 | $13.43 | $2.5K |
| Wahl Bryan | General Counsel | 2023-03-16 | SELL | 337 | $13.43 | $4.5K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2023-03-16 | SELL | 313 | $13.43 | $4.2K |
| Trevejo Jose M. | Chief Medical Officer | 2023-03-16 | SELL | 499 | $13.43 | $6.7K |
| Mottiwala Aziz | Chief Commercial Officer | 2023-03-16 | SELL | 336 | $13.43 | $4.5K |
| Neervannan Seshadri | COO | 2023-03-16 | SELL | 357 | $13.43 | $4.8K |
| Greenstein Leonard M. | CFO | 2023-03-16 | SELL | 5,313 | $13.44 | $71.4K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-03-16 | SELL | 8,791 | $13.76 | $121K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-03-09 | SELL | 5,570 | $15.02 | $83.7K |
| Greenstein Leonard M. | CFO | 2023-02-16 | SELL | 5,000 | $15.12 | $75.6K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-02-15 | SELL | 8,000 | $15.28 | $122.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-02-08 | SELL | 9,000 | $15.14 | $136.3K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-01-23 | SELL | 4,856 | $15.45 | $75K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-01-20 | SELL | 8,240 | $14.57 | $120.1K |
| Greenstein Leonard M. | CFO | 2023-01-19 | SELL | 5,000 | $14.56 | $72.8K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-01-11 | SELL | 3,904 | $15.11 | $59K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-01-10 | SELL | 1,634 | $15.16 | $24.8K |
| Azamian Bobak R. | President/CEO and Board Chair | 2023-01-06 | SELL | 411 | $15 | $6.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2022-12-21 | SELL | 8,000 | $14.57 | $116.6K |
| Azamian Bobak R. | President/CEO and Board Chair | 2022-12-16 | SELL | 535 | $15.01 | $8K |
| Greenstein Leonard M. | CFO | 2022-12-15 | SELL | 5,000 | $14.64 | $73.2K |
| Azamian Bobak R. | President/CEO and Board Chair | 2022-12-14 | SELL | 6,420 | $15.08 | $96.8K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2022-12-02 | SELL | 1,154 | $16.9 | $19.5K |
| Wahl Bryan | General Counsel | 2022-12-02 | SELL | 1,154 | $16.9 | $19.5K |
| Wahl Bryan | General Counsel | 2022-12-01 | SELL | 2,347 | $16.62 | $39K |
| Whitfield Dianne C. | Chief Human Resources Officer | 2022-12-01 | SELL | 2,347 | $16.62 | $39K |
| Greenstein Leonard M. | CFO | 2022-11-17 | SELL | 5,000 | $16.54 | $82.7K |
| Azamian Bobak R. | President and CEO | 2022-11-16 | SELL | 8,000 | $16.86 | $134.9K |
| Mottiwala Aziz | Chief Commercial Officer | 2022-11-15 | SELL | 6,857 | $17.72 | $121.5K |
| Azamian Bobak R. | President and CEO | 2022-11-09 | SELL | 9,000 | $17.87 | $160.8K |
| Greenstein Leonard M. | CFO | 2022-10-20 | SELL | 5,000 | $15.92 | $79.6K |
| Azamian Bobak R. | President and CEO | 2022-10-19 | SELL | 8,000 | $16.92 | $135.4K |
| Azamian Bobak R. | President and CEO | 2022-10-12 | SELL | 9,000 | $15.91 | $143.2K |
| Azamian Bobak R. | President and CEO | 2022-09-21 | SELL | 8,000 | $16.31 | $130.5K |
| Greenstein Leonard M. | CFO | 2022-09-15 | SELL | 5,000 | $16.03 | $80.2K |
| Azamian Bobak R. | President and CEO | 2022-09-14 | SELL | 9,000 | $16.01 | $144.1K |
| Lin Elizabeth Yeu | Director | 2022-09-14 | BUY | 18,400 | $16.12 | $296.6K |
| Greenstein Leonard M. | CFO | 2022-08-18 | SELL | 5,000 | $16.3 | $81.5K |
| Azamian Bobak R. | President and CEO | 2022-08-17 | SELL | 8,000 | $16.59 | $132.7K |
| Ackermann Michael | Director | 2022-05-05 | BUY | 100,000 | $13.5 | $1350K |
| Vivo Capital Fund IX, L.P. | 10% Owner | 2022-05-05 | SELL | 5,374 | $12.25 | $65.8K |
| Vivo Capital Fund IX, L.P. | 10% Owner | 2022-05-04 | SELL | 512,956 | $13.39 | $6868.5K |
| Ackermann Michael | Director | 2021-12-01 | SELL | 5,833 | $24.68 | $144K |
| Azamian Bobak R. | President and CEO | 2021-12-01 | SELL | 5,833 | $24.72 | $144.2K |
| Mottiwala Aziz | Chief Commercial Officer | 2021-11-08 | SELL | 1,889 | $28.11 | $53.1K |
| Mottiwala Aziz | Chief Commercial Officer | 2021-11-05 | SELL | 111 | $28.04 | $3.1K |
| Mottiwala Aziz | Chief Commercial Officer | 2021-11-02 | SELL | 6,000 | $26.78 | $160.7K |
| Ackermann Michael | Director | 2021-11-01 | SELL | 5,833 | $27.82 | $162.3K |
| Azamian Bobak R. | President and CEO | 2021-11-01 | SELL | 5,833 | $27.82 | $162.3K |
| Ackermann Michael | Director | 2021-10-12 | SELL | 5,633 | $26.27 | $148K |
| Azamian Bobak R. | President and CEO | 2021-10-12 | SELL | 5,531 | $26.3 | $145.5K |
| Ackermann Michael | Director | 2021-10-08 | SELL | 200 | $25.03 | $5K |
| Azamian Bobak R. | President and CEO | 2021-10-08 | SELL | 302 | $25.02 | $7.6K |
| Mottiwala Aziz | Chief Commercial Officer | 2021-09-10 | SELL | 2,593 | $22.15 | $57.4K |
| Azamian Bobak R. | President and CEO | 2021-09-01 | SELL | 5,833 | $25.25 | $147.3K |
| Ackermann Michael | Director | 2021-09-01 | SELL | 5,833 | $25.24 | $147.2K |
| Ackermann Michael | Director | 2021-08-11 | SELL | 621 | $25.15 | $15.6K |
| Azamian Bobak R. | President and CEO | 2021-08-11 | SELL | 2,020 | $25.07 | $50.6K |
| Ackermann Michael | Director | 2021-08-09 | SELL | 3,829 | $25 | $95.7K |
| Azamian Bobak R. | President and CEO | 2021-08-09 | SELL | 2,443 | $25.01 | $61.1K |
| Ackermann Michael | Director | 2021-08-05 | SELL | 1,383 | $25 | $34.6K |
| Azamian Bobak R. | President and CEO | 2021-08-05 | SELL | 1,370 | $25 | $34.3K |
| Vivo Capital Fund IX, L.P. | 10% Owner | 2021-06-25 | SELL | 55,684 | $29.79 | $1658.8K |
| Vivo Capital Fund IX, L.P. | 10% Owner | 2021-06-22 | SELL | 201,620 | $29.05 | $5857.1K |
| RTW INVESTMENTS, LP | 10% Owner | 2021-05-07 | SELL | 450,000 | $29.98 | $13491K |
| Vivo Capital Fund IX, L.P. | 10% Owner | 2021-04-14 | SELL | 400 | $30.37 | $12.1K |
| Frazier Life Sciences IX, L.P. | 10% Owner | 2020-10-20 | BUY | 312,500 | $16 | $5000K |
| Horowitz Limited Partnership V | 10% Owner | 2020-10-20 | BUY | 184,375 | $16 | $2950K |
| Vivo Capital Fund IX, L.P. | 10% Owner | 2020-10-20 | BUY | 250,000 | $16 | $4000K |
| Tester Jason E. | Director, 10% Owner | 2020-10-20 | BUY | 171,875 | $16 | $2750K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked